Genpact Ltd (FRA:35G)
€ 28.67 -0.38 (-1.31%) Market Cap: 5.19 Bil Enterprise Value: 6.17 Bil PE Ratio: 8.84 PB Ratio: 2.42 GF Score: 92/100

Genpact Ltd and Amplexor Webinar on In-Depth Review of the Regulatory-as-a-Service Offering (Session B) Transcript

Jan 29, 2020 / 05:00PM GMT
Release Date Price: €39.16 (+0.28%)
Operator

Welcome to the webinar. You have entered as an attendee in listen-only mode.

Sherri Hughes;Smith
Amplexor NV - Senior Director of Marketing - Amplexor Life Sciences

Again, please use the question area within your dashboard, and we'll be more than happy to read your questions aloud to today's panelists.

A little bit of information about who we are. Amplexor is a leader in global content services, and we provide global governance, compliance, digital experience and language services. We continuously have been growing our foundation since 1987, and we have a presence in more than 40 countries, helping customers across key industries, including manufacturing, life sciences and the public sector. Excuse me, I have a bad cold, sorry about that.

We help companies achieve process efficiencies, increase revenue generation, reduce time to market and ensure quality and compliance. Our turnkey solutions support core industry processes and include software technology, consulting, system integration and language and content management

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot